好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | C173 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia

Wednesday 04/17/24
03:30 PM - 05:30 PM MDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Meredith Wicklund, MD, FAAN
Aging, Dementia, and Behavioral Neurology
Participants should become familiar with the indication for and clinical utility of pharmacological and non-pharmacological therapeutics for dementia related cognitive and behavioral symptoms, and become familiar with the first ever disease modifying treatments for dementia and their role in clinical practice.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Evaluations

Event Timeline
03:30 PM - 04:05 PM MDT Speaker Non-pharmacological Treatments in Dementia
Julio C. Rojas-Martinez, MD, PhD
04:05 PM - 04:40 PM MDT Speaker Pharmacological Treatments in Dementia
Lealani M. Acosta, MD, MPH, FAAN
04:40 PM - 05:15 PM MDT Speaker Disease Modifying Treatments in Dementia
Meredith Wicklund, MD, FAAN
05:15 PM - 05:30 PM MDT Q&A Questions & Answers
Meredith Wicklund, MD, FAAN, Julio C. Rojas-Martinez, MD, PhD, Lealani M. Acosta, MD, MPH, FAAN
Faculty Disclosures
Lealani M. Acosta, MD, MPH, FAAN Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Sage, NIH, Bristol Myers Squibb/Fortrea, CND Life Sciences.
Meredith Wicklund, MD, FAAN The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Julio C. Rojas-Martinez, MD, PhD Dr. Rojas-Martinez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferrer International, S.A.. The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. The institution of Dr. Rojas-Martinez has received research support from Amylyx.